Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection

被引:33
作者
Shah, KV [1 ]
Solomon, L [1 ]
Daniel, R [1 ]
Cohn, S [1 ]
Vlahov, D [1 ]
机构
[1] JOHNS HOPKINS UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205
关键词
D O I
10.1128/JCM.35.2.517-519.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared Hybrid Capture, a new technique for detection of human papillomaviruses (HPV), with a PCR assay based on L1 consensus primers. By both methods, the HPV prevalence was higher in human immunodeficiency virus (HIV)-positive women than in HIV-negative women. PCR had a higher sensitivity (0.89 versus 0.48) but lower specificity (0.43 versus 0.93) for detection of Pap smear abnormalities, compared to Hybrid Capture. The higher intensity of hybridization signal by PCR was related to higher estimates of viral load by Hybrid Capture.
引用
收藏
页码:517 / 519
页数:3
相关论文
共 17 条
  • [1] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [2] *CDC, 1992, MORBID MORTAL WEEKLY, V41
  • [3] HUMAN PAPILLOMAVIRUS TESTING BY HYBRID CAPTURE APPEARS TO BE USEFUL IN TRIAGING WOMEN WITH A CYTOLOGIC DIAGNOSIS OF ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE
    COX, JT
    LORINCZ, AT
    SCHIFFMAN, MH
    SHERMAN, ME
    CULLEN, A
    KURMAN, RJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (03) : 946 - 954
  • [4] HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING
    CUZICK, J
    SZAREWSKI, A
    TERRY, G
    HO, L
    HANBY, A
    MADDOX, P
    ANDERSON, M
    KOCJAN, G
    STEELE, ST
    GUILLEBAUD, J
    [J]. LANCET, 1995, 345 (8964) : 1533 - 1536
  • [5] AN EVALUATION OF HUMAN PAPILLOMAVIRUS TESTING FOR INTERMEDIATE-RISK AND HIGH-RISK TYPES AS TRIAGE BEFORE COLPOSCOPY
    HATCH, KD
    SCHNEIDER, A
    ABDELNOUR, MW
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (04) : 1150 - 1157
  • [6] PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN
    HILDESHEIM, A
    SCHIFFMAN, MH
    GRAVITT, PE
    GLASS, AG
    GREER, CE
    ZHANG, T
    SCOTT, DR
    RUSH, BB
    LAWLER, P
    SHERMAN, ME
    KURMAN, RJ
    MANES, MM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) : 235 - 240
  • [7] RISK-FACTORS FOR SQUAMOUS INTRAEPITHELIAL LESIONS ON PAP SMEAR IN WOMEN AT RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    KLEIN, RS
    HO, GYF
    VERMUND, SH
    FLEMING, I
    BURK, RD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) : 1404 - 1409
  • [8] SEROEPIDEMIOLOGY OF HEPATITIS-B VIRUS IN A POPULATION OF INJECTING DRUG-USERS - ASSOCIATION WITH DRUG INJECTION PATTERNS
    LEVINE, OS
    VLAHOV, D
    KOEHLER, J
    COHN, S
    SPRONK, AM
    NELSON, KE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (03) : 331 - 341
  • [9] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CERVICAL NEOPLASIA
    MAIMAN, M
    FRUCHTER, RG
    SERUR, E
    REMY, JC
    FEUER, G
    BOYCE, J
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 38 (03) : 377 - 382
  • [10] HUMAN IMMUNODEFICIENCY VIRUS-INDUCED IMMUNOSUPPRESSION - A RISK FACTOR FOR HUMAN PAPILLOMAVIRUS INFECTION
    MATORRAS, R
    ARICETA, JM
    REMENTERIA, A
    CORRAL, J
    DETERAN, GG
    DIEZ, J
    MONTOYA, F
    RODRIGUEZESCUDERO, FJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) : 42 - 44